DAP_CAT
Grup de Recerca Epidemiològica en Diabetis des de l´Atenció Primària (DAP_CAT)

Responsable del grupo
DAP-CAT - Josep Franch
Josep Franch Nadal
josep.franch@gmail.com
avatar_grups_recerca.png

Publicaciones

Diabetic foot disease carries an intrinsic high risk of mortality and other severe outcomes in type 2 diabetes: a propensity score-matched retrospective population-based study

B. VLACHO, M. BUNDÓ, J. LLUSSÀ, J. REAL, M. MATA-CASES, X. COS, D. TUNDIDOR, F. ZACCARDI, K. KHUNTI, E. JUDE, J. FRANCH-NADAL and D. MAURICIO
Cardiovascular Diabetology. 2024 Jun 19; . doi:10.1186/s12933-024-02303-1; PMID:38898525

Sex and age significantly modulate cardiovascular disease presentation in type 2 diabetes: a large population-based cohort study

A. JIMÉNEZ, B. VLACHO, M. MATA-CASES, J. REAL, D. MAURICIO, J. FRANCH-NADAL and E. ORTEGA
Frontiers in Endocrinology. 2024 May 17; . doi:10.3389/fendo.2024.1344007; PMID:38828412

Value contribution of Etranacogene dezaparvovec for the treatment of severe and moderately severe haemophilia B in Spain through multicriteria decision analysis (MCDA)

D. DIEGO, V. JIMÉNEZ-YUSTE, R. VAZQUEZ, O. HIDALGO, J. POVEDA, J. GIMÉNEZ, J. TRILLO, J. VALLÈS, R. PÉREZ-SANTAMARINA and X. BADIA
HAEMOPHILIA. 2024 Apr 1;

Value contribution of etranacogene dezaparvovec gene therapy in moderately severe and severe haemophilia B through multi-criteria decision analysis

D. GARCÍA-DIEGO, X. BADIA, O. BENÍTEZ-HIDALGO, V. JIMÉNEZ, J. JUÁREZ, R. NÚÑEZ, J. POVEDA, J. TRILLO and J. VALLÉS
HAEMOPHILIA. 2024 Sep 28; . doi:10.1111/hae.15096; PMID:39340327

First manifestation of cardiovascular disease according to age and sex in a Mediterranean country.

Ortega E, Genua I, Mata-Cases M, Roqué M, Vlacho B, Real Gatius J, Franch-Nadal J and Mauricio D
Frontiers in Cardiovascular Medicine. 2024 Sep 17; . doi:10.3389/fcvm.2024.1403363; PMID:39355347